Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bupivacaine liposome nerve blocks to reduce postoperative nausea and vomiting after laparoscopic partial hepatectomy
ChiCTR2500095354Phase 4Not yet recruiting
- Sponsor
- Zhongshan Hospital, Fudan University
- Start
- Jan 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of bupivacaine in postoperative nausea and vomiting (PONV) and postoperative pain (2 arms), sponsored by Zhongshan Hospital, Fudan University. Primary endpoint: QoR-15 score at postoperative day 3. Planned start Jan 2025; status: not yet recruiting.
02
Drugs
bupivacaine
03
Conditions
postoperative nausea and vomiting (PONV)postoperative pain
Beyond the preview
Go deeper on ChiCTR2500095354.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500095354.